Technology Minerals PLC (LSE: TM1) has informed its investors that Recyclus Group, its battery recycling business, has received the final draft approval from the Environment Agency (EA) for its lithium-ion plant in Wolverhampton, West Midlands. Recyclus has accepted the draft permit, with official EA certification expected soon.
Marula Mining (AQSE: MARU), an African-focused mining and development company, updated on the execution of formal documentation in regard to its investments in Tanzania at the Kinusi Copper Project and the Nyorinyori and Bagamoyo Graphite Projects. The company advised that Commercial Agreements have now been entered into with Takela Mining Tanzania Limited on both the Kinusi and the Nyorinyori Graphite Project and with Kusini Gateway Industrial Park Limited on the Bagamoyo Graphite Project.
MARU said it was delighted to confirm that the formal legal documentation on its investment in each of its three Tanzanian projects has now been completed and the Commercial Agreements have been signed by all parties. This is another positive development for Marula and for its mining and development activities.
ImmuPharma PLC (AIM:IMM, OTC:IMMPF) has announced that the US Food and Drug Administration (FDA) has scheduled a pre-investigational new drug (IND) meeting for May 16, 2023, to discuss a phase II/II adaptive trial study protocol for its lead asset P140. The FDA will evaluate a new use for the treatment for chronic idiopathic demyelinating polyneuropathy (CIDP), a rare neurological disease with high medical need.
Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP, OTCQB:OCTHF) has confirmed the permanent appointment of Clarissa Sowemimo-Coker as its chief executive, effective immediately. Sowemimo-Coker has been with the company for over four years and was appointed interim CEO in December.
Shanta Gold Limited (AIM:SHG, OTC:SAAGF) has reported that its spending on local procurement rose dramatically in 2022, according to its latest sustainability report. Community spending increased to US$94 million in 2022 from just US$300,000 the previous year, as the gold miner established a new mine at Singida in Tanzania and began exploration at its West Kenya deposits.
Phoenix Copper Ltd (AIM:PXC, OTCQX:PXCLF) has revealed that recent drilling at the Red Star area of its Empire mine in Idaho, USA, has shown higher-grade, narrow vein mineralization that is expected to lend itself well to underground mining methods.
Bushveld Minerals Limited (AIM:BMN, OTC:BSHVF) has announced that VRFB Holdings Limited (VRFB-H) has signed a conditional agreement with Garnet Commerce and Mustang Energy, under which VRFB-H will acquire a 50% stake in Enerox Holdings. This consolidation is part of a process whereby Bushveld expects to carve out the firm, creating an “entity focused on the VRFB value chain,” expected to be finalized during H2 2023.
Bezant Resources PLC (AIM:BZT) has secured new funding of £750,000 and cleared some remaining consultancy and director fees as it gears up to initiate operations in Namibia, Botswana, and the Philippines. The funding includes a placing and subscription at 0.04p, raising £750,000, with directors and consultants accepting shares worth £175,000 and £101,000, respectively, in lieu of fees at a premium to the placing price.
Iofina PLC (AIM:IOF, OTC:IOFNF) has increased its production slightly in the three months to March despite cooler weather and weather-related disruption, with crystalline iodine output totaling 107.1 metric tonnes (MT) from its IOsorb iodine plants in Oklahoma, up 3.3 MT from the same period in 2022.
First Tin (AIM:1SN), a tin development company with projects in both Germany and Australia, published its final audited results for the year ended 31 December 2022. The company said 2022 has been a year of strong operational performance for First Tin at both its assets in Australia and Germany. It expects 2023 to be another busy and exciting year, where it will continue to build on the momentum achieved last year to add further value to its assets. This will be achieved through the completion of its DFS at Taronga and the release of updated resources for each project in 2023.
Cambridge Cognition (AIM:COG), which develops and markets digital solutions to assess brain health, announced that it has won two sizeable contracts, together worth over £2.1 million, to provide the Company’s CANTAB® cognitive assessments and electronic Clinical Outcome Assessments for two pivotal trials involving patients with a rare disease. The contracts have been awarded by a new customer for the Company with revenues expected to be recognised over the next five years. The company said these contracts will strengthen its presence in the rare disease field and showcase how its cognitive assessments can be used effectively in the development of symptom-modifying treatments.
If anyone reads this article found it useful, helpful? Then please subscribe www.share-talk.com or follow SHARE TALK on our Twitter page for future updates.
Terms of Website Use
All information is provided on an as-is basis. Where we allow Bloggers to publish articles on our platform please note these are not our opinions or views and we have no affiliation with the companies mentioned